Despite the introduction of drug-eluting stents to combat the neointimal hyperplasia that occurred after BMS implantation. in-stent restenosis is still encountered in a significant number of patients. particularly as increasingly complex lesions are tackled by percutaneous coronary intervention. Many biological and mechanical factors interplay to produce restenosis. https://www.adaptsurvival.com/product-category/fondotinta-in-polvere/